On-Demand Webinar: Increasing Efficiency in Clinical and Biotherapeutic Antibody Development
Last Updated: June 2024
Overview
Watch the on-demand webinar for a comprehensive overview of the developments in immunotherapeutics, with a focus on the utilization of B cells in the production of monoclonal antibodies (mAbs). This discussion compares conventional hybridoma technology to more modern advancements, identifying the limitations inherent in traditional mAb discovery methods and advocates for the integration of automated platforms to enhance the efficiency and effectiveness of B cell workflows.
The platforms highlighted include the CellCelector Flex for targeted cell isolation, the iQue®3 High-Throughput Screening by Cytometry Platform for high-throughput cell analysis, and the Octet® BLI Label-Free Detection system for conducting real-time binding assay.
In This Webinar You Will Learn:
- Understand the processes involved in isolating B cells, assessing their antibody production capabilities, and verifying the specificity and affinity of the resultant mAbs
- Appraise the evolution and limitations of traditional mAbs discovery methods
- Compare different platforms for enhancing B cell workflow efficiency
- Discuss empirical data and case studies demonstrating the impact of advanced technologies
Webinar Speaker
Daryl Cole
Scientist
Sartorius
Daryl earned a PhD in Molecular Oncology from King’s College London in 2008 and joined Sartorius in 2021 as a Scientist in the Bio Applications Team, working with the Incucyte, Octet, and iQue but with a focus on iQue applications development. He has over 10 years of experience in a range of scientific fields from cancer research to organoid and stem cell development.
